Global Terminal Vascular Intervention 麻豆原创 Research Report 2024

Publication ID:

PB506244128

Publication Date:

June 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Terminal vascular intervention refers to the use of 1-2 mm thick puncture needles to penetrate the shallow arteries and veins of the human body to enter the human vascular system. With the knowledge of vascular anatomy, the doctor will guide the catheter to the lesion under the guidance of the angiography machine. At this location, a method of injecting a contrast agent through a catheter, displaying the condition of the diseased blood vessel, and treating the disease in the blood vessel. Common body surface puncture points include femoral arteriovenous, radial arteries, subclavian arteriovenous, jugular vein arteriovenous, and so on.
The global Terminal Vascular Intervention market was valued at US$ 2439 million in 2023 and is anticipated to reach US$ 4316.9 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030.
The global market for terminal vascular intervention encompasses a range of medical devices, equipment, and procedures aimed at diagnosing and treating vascular conditions through minimally invasive techniques. This market is strongly influenced by factors such as technological advancements, increasing prevalence of cardiovascular diseases, growing demand for minimally invasive procedures, and expanding healthcare infrastructure in both developed and developing regions.
Key components and segments within the global terminal vascular intervention market include:
Catheters and Guidewires: These are essential tools used for navigating the vascular system and accessing specific areas of interest for diagnostic and therapeutic purposes.
Vascular Stents: These devices are employed to support narrowed or weakened blood vessels, often used in conjunction with angioplasty to restore blood flow.
Angioplasty Balloons: These balloons are used to widen narrowed or obstructed arteries, typically in the context of treating conditions such as atherosclerosis.
Embolization Devices: These devices are utilized to block abnormal blood vessels or control bleeding within the vascular system.
Atherectomy Devices: These tools are employed to remove plaque from blood vessels, contributing to the restoration of healthy blood flow.
Diagnostic Imaging Systems: Various imaging modalities, including angiography machines and intravascular ultrasound, play a critical role in guiding interventional procedures and assessing vascular conditions.
The global market for terminal vascular intervention is supported by a wide array of medical device manufacturers and healthcare providers who are dedicated to advancing the field through research, development, and clinical application. Additionally, the market is shaped by regulatory frameworks, reimbursement mechanisms, and ongoing efforts to improve patient outcomes and safety in vascular interventions.
Several factors drive the growth of the global terminal vascular intervention market, including a rising prevalence of vascular diseases such as peripheral artery disease and coronary artery disease, an increasing geriatric population, technological innovations in interventional cardiology and radiology, and the expansion of healthcare infrastructure in emerging economies.
As the demand for minimally invasive vascular procedures continues to rise, the global market for terminal vascular intervention is poised to experience ongoing advancements, market expansions, and strategic alliances aimed at addressing the evolving needs of patients and healthcare providers. Furthermore, the integration of cutting-edge technologies and the development of advanced materials are expected to further enhance the efficacy and safety of terminal vascular intervention procedures.
This report aims to provide a comprehensive presentation of the global market for Terminal Vascular Intervention, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terminal Vascular Intervention.
Report Scope
The Terminal Vascular Intervention market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Terminal Vascular Intervention market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terminal Vascular Intervention companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Abbott Laboratories
AgioDynamics Inc.
B. Braun
Cardinal Health
Biotronik
Boston Scientific Corporation
Cook Group
C.R. Bard
Depuy Synthesis
Medtronic
Meril Life Sciences India Pvt Ltd
Teleflex
Segment by Type
Catheter Guide
Rotary Cutting Equipment
Embolization Equipment
Thrombectomy Equipment
IVC Filter
Other
Segment by Application
Vascular Disease
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Terminal Vascular Intervention companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Terminal Vascular Intervention 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Catheter Guide
1.2.3 Rotary Cutting Equipment
1.2.4 Embolization Equipment
1.2.5 Thrombectomy Equipment
1.2.6 IVC Filter
1.2.7 Other
1.3 麻豆原创 by Application
1.3.1 Global Terminal Vascular Intervention 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Vascular Disease
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Terminal Vascular Intervention 麻豆原创 Perspective (2019-2030)
2.2 Terminal Vascular Intervention Growth Trends by Region
2.2.1 Global Terminal Vascular Intervention 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Terminal Vascular Intervention Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Terminal Vascular Intervention Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Terminal Vascular Intervention 麻豆原创 Dynamics
2.3.1 Terminal Vascular Intervention Industry Trends
2.3.2 Terminal Vascular Intervention 麻豆原创 Drivers
2.3.3 Terminal Vascular Intervention 麻豆原创 Challenges
2.3.4 Terminal Vascular Intervention 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Terminal Vascular Intervention Players by Revenue
3.1.1 Global Top Terminal Vascular Intervention Players by Revenue (2019-2024)
3.1.2 Global Terminal Vascular Intervention Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Terminal Vascular Intervention 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Terminal Vascular Intervention Revenue
3.4 Global Terminal Vascular Intervention 麻豆原创 Concentration Ratio
3.4.1 Global Terminal Vascular Intervention 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Terminal Vascular Intervention Revenue in 2023
3.5 Terminal Vascular Intervention Key Players Head office and Area Served
3.6 Key Players Terminal Vascular Intervention Product Solution and Service
3.7 Date of Enter into Terminal Vascular Intervention 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Terminal Vascular Intervention Breakdown Data by Type
4.1 Global Terminal Vascular Intervention Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Terminal Vascular Intervention Forecasted 麻豆原创 Size by Type (2025-2030)
5 Terminal Vascular Intervention Breakdown Data by Application
5.1 Global Terminal Vascular Intervention Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Terminal Vascular Intervention Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Terminal Vascular Intervention 麻豆原创 Size (2019-2030)
6.2 North America Terminal Vascular Intervention 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Terminal Vascular Intervention 麻豆原创 Size by Country (2019-2024)
6.4 North America Terminal Vascular Intervention 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Terminal Vascular Intervention 麻豆原创 Size (2019-2030)
7.2 Europe Terminal Vascular Intervention 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Terminal Vascular Intervention 麻豆原创 Size by Country (2019-2024)
7.4 Europe Terminal Vascular Intervention 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Terminal Vascular Intervention 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Terminal Vascular Intervention 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Terminal Vascular Intervention 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Terminal Vascular Intervention 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Terminal Vascular Intervention 麻豆原创 Size (2019-2030)
9.2 Latin America Terminal Vascular Intervention 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Terminal Vascular Intervention 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Terminal Vascular Intervention 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Terminal Vascular Intervention 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Terminal Vascular Intervention 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Terminal Vascular Intervention 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Terminal Vascular Intervention 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Terminal Vascular Intervention Introduction
11.1.4 Abbott Laboratories Revenue in Terminal Vascular Intervention Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 AgioDynamics Inc.
11.2.1 AgioDynamics Inc. Company Detail
11.2.2 AgioDynamics Inc. Business Overview
11.2.3 AgioDynamics Inc. Terminal Vascular Intervention Introduction
11.2.4 AgioDynamics Inc. Revenue in Terminal Vascular Intervention Business (2019-2024)
11.2.5 AgioDynamics Inc. Recent Development
11.3 B. Braun
11.3.1 B. Braun Company Detail
11.3.2 B. Braun Business Overview
11.3.3 B. Braun Terminal Vascular Intervention Introduction
11.3.4 B. Braun Revenue in Terminal Vascular Intervention Business (2019-2024)
11.3.5 B. Braun Recent Development
11.4 Cardinal Health
11.4.1 Cardinal Health Company Detail
11.4.2 Cardinal Health Business Overview
11.4.3 Cardinal Health Terminal Vascular Intervention Introduction
11.4.4 Cardinal Health Revenue in Terminal Vascular Intervention Business (2019-2024)
11.4.5 Cardinal Health Recent Development
11.5 Biotronik
11.5.1 Biotronik Company Detail
11.5.2 Biotronik Business Overview
11.5.3 Biotronik Terminal Vascular Intervention Introduction
11.5.4 Biotronik Revenue in Terminal Vascular Intervention Business (2019-2024)
11.5.5 Biotronik Recent Development
11.6 Boston Scientific Corporation
11.6.1 Boston Scientific Corporation Company Detail
11.6.2 Boston Scientific Corporation Business Overview
11.6.3 Boston Scientific Corporation Terminal Vascular Intervention Introduction
11.6.4 Boston Scientific Corporation Revenue in Terminal Vascular Intervention Business (2019-2024)
11.6.5 Boston Scientific Corporation Recent Development
11.7 Cook Group
11.7.1 Cook Group Company Detail
11.7.2 Cook Group Business Overview
11.7.3 Cook Group Terminal Vascular Intervention Introduction
11.7.4 Cook Group Revenue in Terminal Vascular Intervention Business (2019-2024)
11.7.5 Cook Group Recent Development
11.8 C.R. Bard
11.8.1 C.R. Bard Company Detail
11.8.2 C.R. Bard Business Overview
11.8.3 C.R. Bard Terminal Vascular Intervention Introduction
11.8.4 C.R. Bard Revenue in Terminal Vascular Intervention Business (2019-2024)
11.8.5 C.R. Bard Recent Development
11.9 Depuy Synthesis
11.9.1 Depuy Synthesis Company Detail
11.9.2 Depuy Synthesis Business Overview
11.9.3 Depuy Synthesis Terminal Vascular Intervention Introduction
11.9.4 Depuy Synthesis Revenue in Terminal Vascular Intervention Business (2019-2024)
11.9.5 Depuy Synthesis Recent Development
11.10 Medtronic
11.10.1 Medtronic Company Detail
11.10.2 Medtronic Business Overview
11.10.3 Medtronic Terminal Vascular Intervention Introduction
11.10.4 Medtronic Revenue in Terminal Vascular Intervention Business (2019-2024)
11.10.5 Medtronic Recent Development
11.11 Meril Life Sciences India Pvt Ltd
11.11.1 Meril Life Sciences India Pvt Ltd Company Detail
11.11.2 Meril Life Sciences India Pvt Ltd Business Overview
11.11.3 Meril Life Sciences India Pvt Ltd Terminal Vascular Intervention Introduction
11.11.4 Meril Life Sciences India Pvt Ltd Revenue in Terminal Vascular Intervention Business (2019-2024)
11.11.5 Meril Life Sciences India Pvt Ltd Recent Development
11.12 Teleflex
11.12.1 Teleflex Company Detail
11.12.2 Teleflex Business Overview
11.12.3 Teleflex Terminal Vascular Intervention Introduction
11.12.4 Teleflex Revenue in Terminal Vascular Intervention Business (2019-2024)
11.12.5 Teleflex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott Laboratories
AgioDynamics Inc.
B. Braun
Cardinal Health
Biotronik
Boston Scientific Corporation
Cook Group
C.R. Bard
Depuy Synthesis
Medtronic
Meril Life Sciences India Pvt Ltd
Teleflex

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.